Asparkam (50 tablets)
- $2.80
Out Of Stock
The instruction for medical use
of ASPARKAM-HEALTH medicine
the Trade name
of Asparkam-Zdorovye
the International unlicensed name
Is not present
the Dosage form
of the Tablet Structure One Tablet contains
active agents: tetrahydrate asparaginate magnesium (magnesian salt D, L-of aminosuccinic acid of tetrahydrate) of 175.00 mg, hydrate asparaginate ½ potassium (potassium salt D, L-aminosuccinic acid ½ of hydrate) of 175.00 mg
excipients: potato starch or starch corn, calcium stearate, talc
or
active agent: tablet weight Asparkam of 495.00 mg
excipient: calcium stearate
the Description
of the Tablet of white color, with a flat surface, with risky and a facet. On a surface of tablets the marbling
Pharmacotherapeutic group
Mineral additives is allowed. Other mineral substances.
The ATX A12CX code
Pharmacological properties
the Antiarrhytmic means eliminating deficiency of magnesium and potassium in an organism. Drug restores electrolytic balance in an organism, improves a metabolism in a myocardium and coronary circulation, oppresses atrioventricular conductivity a little, reduces hypersensitivity to cardiac glycosides and reduces manifestations of their toxicity. Has anti-hypoxemic effect.
Indications
- deficiency of magnesium and potassium in an organism
- the arrhythmias caused by electrolytic disturbances
- ventricular premature ventricular contraction, including in a myocardial infarction,
overdose of cardiac glycosides
- coronary heart disease (as a part of complex therapy)
- prevention of intoxication cardiac glycosides
Apply the Route of administration and doses inside, after a meal, on 1-2 tablets 3 times a day. For the purpose of prevention accept on 1 tablet 3 times a day.
Doses and duration of treatment are defined individually by the doctor.
Side effects
Seldom
- nausea, vomiting, diarrhea, dryness in a mouth, thirst, unpleasant feelings or burning in epigastric area, abdominal pain
- disturbance of conductivity of a myocardium, a lowering of arterial pressure, atrioventricular block
- a hyperpotassemia, a gipermagniyemiya
Very seldom
- hyporeflexia, paresthesias, spasms
- neuromuscular blockade, respiratory depression
- an ulcer of a mucous membrane of a digestive tract, bleeding from bodies of a digestive tract
- allergic reactions (an itching, erubescence, rash - at persons with hypersensitivity)
- perspiration
of the Contraindication
- the increased individual sensitivity to drug components
- a hyperpotassemia
- a gipermagniyemiya
- a myasthenia
- sharp and chronic kidney disease, insufficiency of bark of adrenal glands
- atrioventricular block of the III degree
- the profound arterial hypotension, cardiogenic shock (systolic arterial blood pressure is lower, than 90 mm Hg.)
- Addison's disease
- hemolysis
- the anury
Medicinal interactions
Drug improves tolerance of cardiac glycosides and reduces their cardiotoxic action.
At simultaneous use with kaliysberegayushchy diuretics and inhibitors of angiotensin-converting enzyme the risk of development of a hyperpotassemia in this connection control of level of potassium in blood plasma is necessary increases.
Slows down absorption of oral forms of tetracycline, salts of iron and sodium fluoride (it is necessary to adhere to a three-hour interval between receptions).
At simultaneous use with inhibitors of angiotensin-converting enzyme, beta blockers, cyclosporine, kaliysberegayushchy diuretics, heparin, non-steroidal anti-inflammatory drugs the oppressing influence on an intestines vermicular movement amplifies.
At simultaneous use with the anti-depolarizing muscle relaxants the neuromuscular blockade amplifies, with anesthetics – the central nervous system is oppressed.
Drug reduces efficiency of cardiac glycosides, Neomycinum, polymyxin B, tetracycline and streptomycin.
Drugs of calcium reduce efficiency of Asparkama-Zdorovye.
At prolonged use the level of potassium and magnesium in blood, ECG indicators is recommended to control special instructions. Considering that potassium drugs at intake can irritate a mucous membrane of digestive tract, it is not recommended to take the drug on an empty stomach. At patients with insufficiency of bark of adrenal glands the risk of development of a hyperpotassemia increases.
The period of pregnancy and a lactation
during pregnancy and feeding by a breast appoint drug in case the advantage of use exceeds potential risk for the fruit/child and under observation of the doctor.
Use in pediatrics
the Clinical data on use of drug for treatment of children are absent.
Influence on a possibility of control of vehicles and mechanisms
Drug does not influence speed of response at control of motor transport or work with difficult mechanisms.
Overdose
Symptoms of a hyperpotassemia and gipermagniyemiya: bradycardia, arrhythmia, respiratory depression, hyporeflexia, a disorientation, face reddening, thirst, a lowering of arterial pressure, an abdominal pain, paralysis of muscles, metal smack in a mouth, constraint and paresthesias in extremities, on the electrocardiogram is registered increase in amplitude of a tooth of T, decrease in amplitude of a tooth P, expansion of the QRS complex.
Treatment: gastric lavage and parenteral administration of drugs of calcium, symptomatic therapy.
A form of release and packing
On 10 or 50 tablets in blister strip packaging from a film of polyvinylchloride and aluminum foil.
On 5 blister strip packagings on 10 tablets or 1 blister strip packaging on 50 tablets together with the instruction for medical use in the state and Russian languages place in a box of cardboard.
Packing on 140 blister strip packagings on 50 tablets without investment in a box together with the corresponding number of instructions for medical use in the state and Russian languages it is allowed place in a box from corrugated fibreboard.
To Store storage conditions in the dry place at a temperature from 15 ºС up to 25 ºС
to Store out of children's reach!
3 years
not to apply a period of storage after the expiry date specified on packing!
Prescription status
Without prescription
LLC Pharmaceutical Company Zdorovye Producer, Ukraine
the Owner of the registration certificate
of LLC Pharmaceutical Company Zdorovye, Ukraine
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods) the Address: Limited liability partnership of Pharmaceutical Euro, 050039, Almaty, Mailing St., 72, apartment 34 Phone number: +7 (727) 271-10-17Факс: +7(727) 271-84-97Эл. address: pharmevro@mail.ru
of ASPARKAM-HEALTH medicine
the Trade name
of Asparkam-Zdorovye
the International unlicensed name
Is not present
the Dosage form
of the Tablet Structure One Tablet contains
active agents: tetrahydrate asparaginate magnesium (magnesian salt D, L-of aminosuccinic acid of tetrahydrate) of 175.00 mg, hydrate asparaginate ½ potassium (potassium salt D, L-aminosuccinic acid ½ of hydrate) of 175.00 mg
excipients: potato starch or starch corn, calcium stearate, talc
or
active agent: tablet weight Asparkam of 495.00 mg
excipient: calcium stearate
the Description
of the Tablet of white color, with a flat surface, with risky and a facet. On a surface of tablets the marbling
Pharmacotherapeutic group
Mineral additives is allowed. Other mineral substances.
The ATX A12CX code
Pharmacological properties
the Antiarrhytmic means eliminating deficiency of magnesium and potassium in an organism. Drug restores electrolytic balance in an organism, improves a metabolism in a myocardium and coronary circulation, oppresses atrioventricular conductivity a little, reduces hypersensitivity to cardiac glycosides and reduces manifestations of their toxicity. Has anti-hypoxemic effect.
Indications
- deficiency of magnesium and potassium in an organism
- the arrhythmias caused by electrolytic disturbances
- ventricular premature ventricular contraction, including in a myocardial infarction,
overdose of cardiac glycosides
- coronary heart disease (as a part of complex therapy)
- prevention of intoxication cardiac glycosides
Apply the Route of administration and doses inside, after a meal, on 1-2 tablets 3 times a day. For the purpose of prevention accept on 1 tablet 3 times a day.
Doses and duration of treatment are defined individually by the doctor.
Side effects
Seldom
- nausea, vomiting, diarrhea, dryness in a mouth, thirst, unpleasant feelings or burning in epigastric area, abdominal pain
- disturbance of conductivity of a myocardium, a lowering of arterial pressure, atrioventricular block
- a hyperpotassemia, a gipermagniyemiya
Very seldom
- hyporeflexia, paresthesias, spasms
- neuromuscular blockade, respiratory depression
- an ulcer of a mucous membrane of a digestive tract, bleeding from bodies of a digestive tract
- allergic reactions (an itching, erubescence, rash - at persons with hypersensitivity)
- perspiration
of the Contraindication
- the increased individual sensitivity to drug components
- a hyperpotassemia
- a gipermagniyemiya
- a myasthenia
- sharp and chronic kidney disease, insufficiency of bark of adrenal glands
- atrioventricular block of the III degree
- the profound arterial hypotension, cardiogenic shock (systolic arterial blood pressure is lower, than 90 mm Hg.)
- Addison's disease
- hemolysis
- the anury
Medicinal interactions
Drug improves tolerance of cardiac glycosides and reduces their cardiotoxic action.
At simultaneous use with kaliysberegayushchy diuretics and inhibitors of angiotensin-converting enzyme the risk of development of a hyperpotassemia in this connection control of level of potassium in blood plasma is necessary increases.
Slows down absorption of oral forms of tetracycline, salts of iron and sodium fluoride (it is necessary to adhere to a three-hour interval between receptions).
At simultaneous use with inhibitors of angiotensin-converting enzyme, beta blockers, cyclosporine, kaliysberegayushchy diuretics, heparin, non-steroidal anti-inflammatory drugs the oppressing influence on an intestines vermicular movement amplifies.
At simultaneous use with the anti-depolarizing muscle relaxants the neuromuscular blockade amplifies, with anesthetics – the central nervous system is oppressed.
Drug reduces efficiency of cardiac glycosides, Neomycinum, polymyxin B, tetracycline and streptomycin.
Drugs of calcium reduce efficiency of Asparkama-Zdorovye.
At prolonged use the level of potassium and magnesium in blood, ECG indicators is recommended to control special instructions. Considering that potassium drugs at intake can irritate a mucous membrane of digestive tract, it is not recommended to take the drug on an empty stomach. At patients with insufficiency of bark of adrenal glands the risk of development of a hyperpotassemia increases.
The period of pregnancy and a lactation
during pregnancy and feeding by a breast appoint drug in case the advantage of use exceeds potential risk for the fruit/child and under observation of the doctor.
Use in pediatrics
the Clinical data on use of drug for treatment of children are absent.
Influence on a possibility of control of vehicles and mechanisms
Drug does not influence speed of response at control of motor transport or work with difficult mechanisms.
Overdose
Symptoms of a hyperpotassemia and gipermagniyemiya: bradycardia, arrhythmia, respiratory depression, hyporeflexia, a disorientation, face reddening, thirst, a lowering of arterial pressure, an abdominal pain, paralysis of muscles, metal smack in a mouth, constraint and paresthesias in extremities, on the electrocardiogram is registered increase in amplitude of a tooth of T, decrease in amplitude of a tooth P, expansion of the QRS complex.
Treatment: gastric lavage and parenteral administration of drugs of calcium, symptomatic therapy.
A form of release and packing
On 10 or 50 tablets in blister strip packaging from a film of polyvinylchloride and aluminum foil.
On 5 blister strip packagings on 10 tablets or 1 blister strip packaging on 50 tablets together with the instruction for medical use in the state and Russian languages place in a box of cardboard.
Packing on 140 blister strip packagings on 50 tablets without investment in a box together with the corresponding number of instructions for medical use in the state and Russian languages it is allowed place in a box from corrugated fibreboard.
To Store storage conditions in the dry place at a temperature from 15 ºС up to 25 ºС
to Store out of children's reach!
3 years
not to apply a period of storage after the expiry date specified on packing!
Prescription status
Without prescription
LLC Pharmaceutical Company Zdorovye Producer, Ukraine
the Owner of the registration certificate
of LLC Pharmaceutical Company Zdorovye, Ukraine
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods) the Address: Limited liability partnership of Pharmaceutical Euro, 050039, Almaty, Mailing St., 72, apartment 34 Phone number: +7 (727) 271-10-17Факс: +7(727) 271-84-97Эл. address: pharmevro@mail.ru
Related Products
Legacy Pharmaceuticals (Switzerland)
Solcoseryl 5's 5 ml solution for injection in ampoules
$66.30
Out Of Stock
